Research - , ,
Due to the high frequency of cases of Dry Eye Disease in Canada and around the world, it is clear that conventional treatment is insufficient. The goal of 20/20 OptimEyes is to use u-celles technology to better control the release of drug. This will allow for prolonged release of the drug, as well as the mucoadhesive properties will allow prolonged exposure to the eye.
Gmail
Typekit
Mobile Friendly
YouTube